This information was published on 2025-05-30T10:11:38 for IP Right Registration Published.
| Field | Value |
| (210) | 2497989 |
| (220) |
12 Nov 2024
|
| (300) |
GB, 22 Oct 2024, UK00004115166
|
| (511) (510) |
Class 5
Hyaluronic acid based barrier substance injected between prostate and rectum to mitigate the toxicity effects of radiotherapy treatments of prostate cancer; gel substance injected between prostate and rectum for creating a space between the two for protecting the rectum from radiation during prostate cancer radiation treatment; a barrier product to create a space between the prostate and the rectal wall to minimise the risk of radiation toxicity impacting on the rectum during radiotherapy treatment for prostate cancer Class 10 Medical devices, namely, synthetic implants in the nature of a hyaluronic acid based barrier substance injected between prostate and rectum to mitigate the toxicity effects of radiotherapy treatments of prostate cancer; Medical devices, namely, synthetic implants in the nature of a gel injected between prostate and rectum for creating a space between the two for protecting the rectum from radiation during prostate cancer radiation treatment; kits that contain applicators consisting of a needle and a hyaluronic acid based substance for use in medical and surgical procedures; surgical and medical apparatus and instruments; a medical barrier device to create a space between the prostate and the rectal wall to minimise the risk of radiation toxicity impacting on the rectum during radiotherapy treatment for prostate cancer |
| (540) | TOXBAR |
| (550) | Word |
| (730) |
Athena Medtec Limited
|
| (750) |
PHILLIPS ORMONDE FITZPATRICK
|
Find out more about publications on the About page.